PRPL News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$10.4M

Volume

41.08K

Next Earnings

November 3rd

Mkt Cap

$10.4M

Volume

41.08K

Next Earnings

November 3rd

Chart Financials Earnings News About Insider Filings

Procter & Gamble Pre-Q1 Earnings: Is It Wise to Buy the Stock Now?Procter & Gamble is set to report Q1 fiscal 2027 results on October 22, with sales projected to rise 1.4% to $22.7B but EPS expected to decline 5%. Higher input costs and inflation are pressuring gross margins, projected to contract 120 basis points. While the company benefits from innovation and pricing strategies, valuation concerns persist with a forward P/E of 22.02X, above industry averages.Zacks Investment Research · Oct 15, 2026

How Kimberly-Clark Navigates Slower Growth Across Consumer Categories?Kimberly-Clark (KMB) maintains resilience with its 10th consecutive quarter of solid volume-and-mix performance and stable market share despite moderating category growth. North American category growth slowed to 1.9% in Q2 2026 amid consumer pressures, while the company achieved notable market-share gains in international markets like Indonesia (390 basis points in diapers) and Brazil (70 basis points). However, Zacks rates KMB as a Sell with shares down 7.7% in three months, and consensus estimates project minimal earnings growth ahead.Zacks Investment Research · Oct 14, 2026

Sleep.ai to Present 10 Scientific Studies at SLEEP 2026, Highlighting Advances in Digital Sleep Intelligence and Product ValidationSleep.ai announced that 10 scientific studies will be presented at SLEEP 2026, including three original AI/ML analyses on smartphone-based sleep detection and sleep apnea prediction, plus seven partner validation studies on sleep-related products. The presentations underscore Sleep.ai's commitment to evidence-based sleep innovation, leveraging over one billion hours of sleep data and 250+ scientific studies.GlobeNewswire Inc. · Jun 11, 2026

Somnigroup (SGI) Q2 Revenue Jumps 53%Somnigroup International reported Q2 2025 earnings with non-GAAP EPS exceeding analyst estimates, driven by Mattress Firm acquisition and direct-to-consumer sales growth. Despite strong revenue growth, integration costs impacted net income and margins.The Motley Fool · Aug 7, 2025

Breaking Down Purple Innovation: 6 Analysts Share Their ViewsPurple Innovation (NASDAQ:PRPL) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 2 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 1 1 0 0 3M Ago 0 0 1 0 0 Analysts have recently evaluated Purple Innovation and provided 12-month price targets. The average target is $2.25, accompanied by a high estimate of $2.50 and a low estimate of $2.00. Witnessing a positive shift, the current average has risen by 45.16% from the previous average price target of $1.55. Diving into Analyst Ratings: An In-Depth Exploration In examining recent analyst actions, we gain insights into how financial experts perceive Purple Innovation. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Seth Basham Wedbush Maintains Outperform $2.25 - Matt Koranda Roth MKM Maintains Buy $2.50 $2.50 Matt Koranda Roth MKM Raises Buy $2.50 $2.00 Jeremy Hamblin Craig-Hallum Raises Hold $2.00 $1.00 Seth Basham Wedbush Raises Outperform $2.25 $1.25 Matt Koranda Roth MKM Raises Neutral $2.00 $1.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Purple Innovation. This information offers a snapshot of how analysts ...Full story available on Benzinga.comBenzinga · May 8, 2024

Purple Innovation (PRPL) Reports Q1 Loss, Lags Revenue EstimatesPurple Innovation (PRPL) delivered earnings and revenue surprises of -26.67% and 1.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 7, 2024

Is JAPAN TOB (JAPAY) Stock Outpacing Its Consumer Staples Peers This Year?Here is how JAPAN TOB (JAPAY) and Purple Innovation (PRPL) have performed compared to their sector so far this year.Zacks Investment Research · Apr 18, 2024

Fast-paced Momentum Stock Purple Innovation (PRPL) Is Still Trading at a BargainPurple Innovation (PRPL) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.Zacks Investment Research · Apr 11, 2024

Why Fast-paced Mover Purple Innovation (PRPL) Is a Great Choice for Value InvestorsIf you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Purple Innovation (PRPL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.Zacks Investment Research · Mar 26, 2024

Is Edgewell Personal Care (EPC) Stock Outpacing Its Consumer Staples Peers This Year?Here is how Edgewell Personal Care (EPC) and Purple Innovation (PRPL) have performed compared to their sector so far this year.Zacks Investment Research · Mar 21, 2024

PRPLPurple Innovation, Inc. Common Stock

PRPL

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any PRPL yet.

Related Tickers

Earnings

Mkt Cap

$10.4M

Volume

41.08K

Next Earnings

November 3rd